The CRAFFT is a (updated version of a) behavioral health screening tool for use with children ages and is recommended by the American Academy of . The CRAFFT Screening Interview. The CRAFFT is a behavioral health screening tool for use with children under the age of 21 and is recommended by the. CRAFFT is a screening tool for adolescent substance use that has been validated in outpatient general medical settings. This is the first study to examine its use.
|Published (Last):||28 March 2009|
|PDF File Size:||6.59 Mb|
|ePub File Size:||10.29 Mb|
|Price:||Free* [*Free Regsitration Required]|
At the conclusion of the medical visit, the primary care provider ie, physician or nurse practitioner invited eligible patients to participate in the study.
CRAFFT Screening Tool | Patient Centered Primary Care Institute
Craffh in to customize your interests Sign in to your personal account. There were a total of 59 abuse diagnoses; 16 were for alcohol alone, 30 for other drugs alone, and 13 for both alcohol and other drugs.
For example, a score of 4 or higher should raise suspicion of substance dependence. Frequencies of participants’ demographic characteristics and substance-related diagnostic classifications during the previous 12 months are presented in Table 1.
The sensitivity and specificity 0. CRAFFT is a screening tool for adolescent substance use that has been validated in outpatient general medical settings. All research assistants read the ADI manual, watched model interviews, practiced on volunteers, and drafft videotaped conducting practice interviews. Few comparable validation studies have been conducted in general adolescent clinic settings, and none of these included both a risk assessment ie, the POSIT scale and a psychiatric diagnostic interview ie, the ADI.
History Philosophy Portal Psychologist. If universal screening is to improve, health care systems must find ways to provide the tool resources needed for assessment of substance-using adolescents. Substance-related problems and disorders were highly prevalent in the clinic we studied, affecting more than 1 in 4 patients.
A pilot study among adolescent patients who had used alcohol and other drugs found that CRAFFT had promising concurrent validity compared with a more lengthy scale.
Early Intervention for Adolescents. Also unknown is the likely outcome of universal screening, ie, what proportion of adolescent patients have alcohol- and drug-related disorders. Create a free personal account to download free article PDFs, sign up for alerts, and more. There are limitations to the generalizability of our findings regarding diagnostic classifications.
The first three items Part A evaluate alcohol and drug use over the past year and screennig other six Part B ask about situations in which the respondent used drugs or alcohol and any consequences of the usage. A research assistant explained the study procedures to interested patients and obtained signed assent.
The Children’s Hospital Boston Committee on Clinical Investigation institutional review board waived the requirement for parental consent in accordance with current guidelines for adolescent health research. Studies proposing new intervention strategies for those who screen positive are urgently needed.
CRAFFT Screening Test – Wikipedia
The findings on prevalence may be further limited, in that the study sample, although generally reflective of the clinic population at large, was not selected randomly. These findings also suggest a need to increase the capacity of systems and communities to provide substance abuse treatment for adolescents.
The older version of the questionnaire contains 9 items in total, answered in a “yes” or “no” format. Some providers may therefore choose to further assess those adolescents whose score is only 1. Participants were consecutively recruited in approximately half of the 12 clinic sessions conducted each week.
However, some adolescents may be reluctant to discuss their alcohol and other drug use with the pediatrician, even when parents are not present. In our own metropolitan area, adolescents needing substance abuse treatment are most often referred to adult programs because so few adolescent-only programs exist.
Journal of studies on alcohol. CRAFFT scores were also positively correlated with a history of psychiatric trauma and past suicide attempts, which is consistent with the results of previous studies associating pediatric substance use and traumatic life events with an increased risk of suicide.
Almost 1 in 6 Purchase access Subscribe to the journal. Despite these sccreening, this study provides strong supportive evidence for the criterion validity of the CRAFFT test. In clinic settings such as ours, one fourth of patients need at least a brief intervention, and one sixth likely need referral to a treatment specialist.
Validity of the CRAFFT Substance Abuse Screening Test Among Adolescent Clinic Patients
Current Drug Abuse Reviews. Am J Obstet Gynecol.
Sensitivity, specificity, and positive and negative predictive values of a CRAFFT score of 2 or higher for identifying screenkng of the 3 screening categories are presented in Table 2. During the month recruitment period, providers invited adolescent patients to participate in the study.
To be practical, they must be designed to be completed by patients within the usual waiting time, and scoring procedures must be sufficiently streamlined so that results can be given to the physician before the medical visit begins. A receiver operating characteristic area of 1 upper-left corner of the graph theoretically tooo that the test is always correct, and an area of 0. Some adolescents may answer this cradft affirmatively based on having ridden in a car with an intoxicated family member, rather than driving after drinking or riding with an intoxicated peer.
More than one half of patients in our clinic had used alcohol or other drugs during the past year, and more than one fourth had experienced serious substance-related problems. Preventive services in a health maintenance organization. The Nation’s Number 1 Health Problem. By contrast, healthier and less-affected patients may have been more likely scdeening agree to participate in the study, resulting in self-selection bias and lower than actual estimates of prevalence.
A Guide for Clinicians and Researchers.